EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort

Piero Ruscitti, Damiano Currado, Felice Rivellese, Marta Vomero, Luca Navarini, Paola Cipriani, Costantino Pitzalis, Roberto Giacomelli

Arthritis Research & Therapy · 2024

DOI: 10.1186/s13075-024-03392-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Research & Therapy, 2024. Verfasst von Piero Ruscitti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Delta 6 Building, PO box 67100, L'Aquila, It…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Proteasome Endopeptidase Complex, Diabetes Mellitus, Type 2, Ubiquitin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: PRIN 2022, National Institute for Health Research Barts Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Based on the recent evidence of IL-1 inhibition in patients with rheumatoid arthritis (RA) and concomitant type 2 diabetes (T2D), we evaluated the synovial tissue expression of IL-1 related genes in relationship to the ubiquitin-proteasome system and the effects of insulin on ubiquitinated proteins in fibroblast-like synoviocytes (FLSs). METHODS: The synovial expression of IL-1 pathway genes was compared in early (< 1 year) treatment-naïve RA patients with T2D (RA/T2D n = 16) and age- and sex-matched RA patients without T2D (n = 16), enrolled in the Pathobiology of Early Arthritis Cohort (PEAC). The synovial expression of ubiquitin in macrophages and synovial lining fibroblasts was also assessed by Immunohistochemistry/immunofluorescence and correlated with synovial pathotypes. Finally, FLSs from RA patients (n = 5) were isolated and treated with human insulin (200 and 500 nM) and ubiquitinated proteins were assessed by western blot. RESULTS: Synovial tissues of RA/T2D patients were characterised by a consistent reduced expression of ubiquitin-proteasome genes. More specifically, ubiquitin genes (UBB, UBC, and UBA52) and genes codifying proteasome subunits (PSMA2, PSMA6, PSMA7, PSMB1, PSMB3, PSMB4, PSMB6, PSMB8, PSMB9, PSMB10, PSMC1, PSMD9, PSME1, and PSME2) were significantly lower in RA/T2D patients. On the contrary, genes regulating fibroblast functions (FGF7, FGF10, FRS2, FGFR3, and SOS1), and genes linked to IL-1 pathway hyper-activity (APP, IRAK2, and OSMR) were upregulated in RA/T2D. Immunohistochemistry showed a significant reduction of the percentage of ubiquitin-positive cells in synovial tissues of RA/T2D patients. Ubiquitin-positive cells were also increased in patients with a lympho-myeloid pathotype compared to diffuse myeloid or pauci-immune-fibroid. Finally, in vitro experiments showed a reduction of ubiquitinated proteins in RA-FLSs treated with a high concentration of insulin (500 nM). CONCLUSIONS: A different IL-1 pathway gene expression was observed in the synovial tissues of early treatment-naïve RA/T2D patients, linked to decreased expression of the ubiquitin-proteasome system. These findings may provide a mechanistic explanation of the observed clinical benefits of IL-1 inhibition in patients with RA and concomitant T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidProteasome Endopeptidase ComplexDiabetes Mellitus, Type 2UbiquitinInterleukin-1Synovial MembraneHumansMaleFemaleMiddle AgedSignal TransductionAgedCohort StudiesSynoviocytesBlotting, WesternAdultImmunohistochemistryCells, CulturedInsulin

Stichwörter der Autor:innen

IL-1β, ubiquitinOf Early Arthritis Cohort study (PEAC)PathobiologyRheumatoid arthritisSynovial biopsyType 2 diabetes

Substanzen

Proteasome Endopeptidase ComplexUbiquitinInterleukin-1Insulin

Autor:innen und Institutionen

  • Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Delta 6 Building, PO box 67100, L'Aquila, Italy. piero.ruscitti@univaq.it.
  • Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Campus Bio-Medico, Via Álvaro del Portillo 200, 00128, Rome, Italy.
  • Rheumatology and Clinical Immunology, Department of Medicine, University of Rome "Campus Biomedico", School of Medicine, Rome, Italy.
  • Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK.
  • Barts Health NHS Trust & Barts Biomedical Research Centre (BRC) National Institute for Health and Care Research (NIHR), London, UK.
  • Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Delta 6 Building, PO box 67100, L'Aquila, Italy.

Förderung

  • PRIN 2022
  • National Institute for Health Research Barts Biomedical Research Centre

Zitieren

APA

Ruscitti, P., Currado, D., Rivellese, F., Vomero, M., Navarini, L., Cipriani, P., Pitzalis, C., & Giacomelli, R. (2024). Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-024-03392-9

Vancouver

Ruscitti P, Currado D, Rivellese F, Vomero M, Navarini L, Cipriani P, et al. Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort. Arthritis Research & Therapy. 2024. doi:10.1186/s13075-024-03392-9

BibTeX
@article{Ruscitti2024,
  author = {Ruscitti, Piero and Currado, Damiano and Rivellese, Felice and Vomero, Marta and Navarini, Luca and Cipriani, Paola and Pitzalis, Costantino and Giacomelli, Roberto},
  title = {Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort},
  journal = {Arthritis Research & Therapy},
  year = {2024},
  doi = {10.1186/s13075-024-03392-9}
}
Kostenlos starten →